BROWSE·page 159 of 257

Browse EX-10 agreements

3,074 matching material contract exhibits.


EX-10.1

HARLEY-DAVIDSON, INC.

HARLEY-DAVIDSON, INC.

2020 INCENTIVE STOCK PLAN

1. Purposes, History and Effective Date.

(a) Purpose. The Harley-Davidson, Inc. 2020 Incentive Stock Plan has two complementary purposes: (i) to attract and retain outstanding individuals to serve as officers and other employees and (ii) to increase shareholder value. This Plan provides participants incentives to increase shareholder value by offering the opportunity to acquire shares of the Company’s common stock or receive monetary payments based on the value of such common stock on the potentially favorable terms that this Plan provides.

…

EX-10.1·10-Q·CIK 793952·ACC 0000793952-26-000061·Filed Aug 05, 2026, 16:02 ET

EXHIBIT 10.1

SOLAREDGE TECHNOLOGIES, INC.


Exhibit 10.1

EMPLOYMENT AGREEMENT

THIS AGREEMENT is entered into as of , by and between SolarEdge Technologies Ltd. (the“Company”) having an address at 1 HaMada Street, Herzliya, Israel and Maoz Sigron, Israeli ID No.                of                         (the “Employee”).

WHEREAS: The Company desires to employ the Employee in the position of CFO (the “Position”) and the Employee desires to enter into such employment, on the terms and conditions hereinafter set forth.

NOW, THEREFORE, in consideration of the respective agreements of the parties contained herein, the parties agree as follows:

…

EX-10.1·10-Q·CIK 1419612·ACC 0001178913-26-003854·Filed Aug 05, 2026, 16:02 ET

EX-10.3

Sarepta Therapeutics, Inc.

SAREPTA THERAPEUTICS, INC.

2026 EQUITY INCENTIVE PLAN

STOCK OPTION AWARD AGREEMENT

NOTICE OF STOCK OPTION GRANT

The above-named Participant (the “Participant”) has been granted an Option (the “Option”) to purchase the number of shares of Common Stock of Sarepta Therapeutics, Inc. (the “Company”) set forth below (the “Shares”), pursuant and subject to the terms and conditions of the 2026 Equity Incentive Plan (the “Plan”) and this Stock Option Award Agreement, including this Notice of Stock Option Grant (the “Notice of Grant”) and the Terms and Conditions of Stock Option Grant attached hereto as Exhibit A, (together, this “Award Agreement”), as follows:

Date of Grant

Vesting Commencement Date

Exercise Price per Share

Total Number of Shares Granted

Total Exercise Price

Type of Option:

Term/Expiration Date:

Vesting Schedule

…

EX-10.3·10-Q·CIK 873303·ACC 0001193125-26-335003·Filed Aug 05, 2026, 16:01 ET

EX-10.4

Sarepta Therapeutics, Inc.

SAREPTA THERAPEUTICS, INC.

2026 EQUITY INCENTIVE PLAN

RESTRICTED STOCK UNIT AWARD AGREEMENT

NOTICE OF RESTRICTED STOCK UNIT GRANT

The above-named Participant (the “Participant”) has been granted the number of restricted stock units (the “RSUs”) set forth below giving the Participant the conditional right to receive, without payment therefor, one share of Common Stock of Sarepta Therapeutics, Inc. (the “Company”) with respect to each RSU forming part of the award, pursuant and subject to the terms and conditions of the 2026 Equity Incentive Plan (the “Plan”) and this Restricted Stock Unit Award Agreement, including this Notice of Restricted Stock Unit Grant (the “Notice of Grant”) and the Terms and Conditions of Restricted Stock Unit Grant attached hereto as Exhibit A, (this “Award Agreement”), as follows:

Date of Grant

Vesting Commencement Date

Number of RSUs

Vesting Schedule

…

EX-10.4·10-Q·CIK 873303·ACC 0001193125-26-335003·Filed Aug 05, 2026, 16:01 ET

EX-10.5

SIMMONS FIRST NATIONAL CORP

AMENDED AND RESTATED

SIMMONS FIRST NATIONAL CORPORATION

2023 STOCK AND INCENTIVE PLAN

PERFORMANCE SHARE UNIT AGREEMENT

Grant Details

Participant Name: [ ]

…

EX-10.5·10-Q·CIK 90498·ACC 0001628280-26-053273·Filed Aug 05, 2026, 16:01 ET

EX-10.3

SIMMONS FIRST NATIONAL CORP

AMENDED AND RESTATED

SIMMONS FIRST NATIONAL CORPORATION

2023 STOCK AND INCENTIVE PLAN

RESTRICTED STOCK UNIT AGREEMENT -

ASSOCIATE

Grant Details\
Participant Name: [ ]\
Award Type: Restricted Stock Units\
Award Date: [ ]\
Total Number of Restricted Stock Units Awarded: [ ]\
Period of Restriction:

…

EX-10.3·10-Q·CIK 90498·ACC 0001628280-26-053273·Filed Aug 05, 2026, 16:01 ET

EX-10.2

SIMMONS FIRST NATIONAL CORP

AMENDED AND RESTATED

SIMMONS FIRST NATIONAL CORPORATION

2023 STOCK AND INCENTIVE PLAN

RESTRICTED STOCK UNIT AGREEMENT

NON-EMPLOYEE DIRECTOR

This Restricted Stock Unit Agreement (this “RSU Agreement”) is effective on [●] (the “Award Date”), and is entered into between Simmons First National Corporation, an Arkansas corporation (the “Company”), and [●] (the “Director”).

WHEREAS, the Board of Directors of the Company (the “Board”) is authorized to make grants of Restricted Stock Units to Non-Employee Directors under the Amended and Restated Simmons First National Corporation 2023 Stock and Incentive Plan (the “Plan”); and

WHEREAS, the Board approved the grant of Restricted Stock Units pursuant to the Plan to the Director, effective as of the Award Date, provided that the Director is a Non-Employee Director on the Award Date.

NOW, THEREFORE, in consideration of the foregoing recitals and the mutual promises set forth below, the parties hereto agree as follows:

…

EX-10.2·10-Q·CIK 90498·ACC 0001628280-26-053273·Filed Aug 05, 2026, 16:01 ET

EX-10.4

SIMMONS FIRST NATIONAL CORP

AMENDED AND RESTATED

SIMMONS FIRST NATIONAL CORPORATION

2023 STOCK AND INCENTIVE PLAN

RESTRICTED STOCK UNIT AGREEMENT -

NEW HIRE AND RETENTION

Grant Details\
Participant Name: [ ]\
Award Type: Restricted Stock Units\
Award Date: [ ]\
Total Number of Restricted Stock Units Awarded: [ ]\
Period of Restriction:

…

EX-10.4·10-Q·CIK 90498·ACC 0001628280-26-053273·Filed Aug 05, 2026, 16:01 ET

EX-10.1

ELI LILLY & Co

Exhibit 10.1 The Lilly Director’s Deferral Plan, as amended

ELI LILLY AND COMPANY

THE LILLY DIRECTORS' DEFERRAL PLAN

(as Amended and Restated Effective May 27, 2026)

Preamble

The Lilly Directors’ Deferral Plan has been established by the Company for the purpose of providing an opportunity for Directors of the Company who are not salaried employees of the Company to voluntarily defer receipt of some or all of their meeting fees and retainer and to share in the long-term growth of the Company by acquiring, on a deferred basis, an ownership interest in the Company. Subject to adjustment as provided in Section 5(f), and contingent upon receiving approval of the Company’s shareholders, effective January 1, 2017, the aggregate number of shares of Eli Lilly and Company common stock that may be issued or transferred under this Plan is 1,500,000. For the period beginning April 29, 2003, and ending December 31, 2016, the aggregate number of authorized shares was 750,000. Shares issued under the Plan may be authorized and unissued shares or treasury shares.

…

EX-10.1·10-Q·CIK 59478·ACC 0000059478-26-000081·Filed Aug 05, 2026, 14:40 ET

EX-10.2

5C Lending Partners Corp.

FIRST AMENDMENT TO LOAN, SECURITY
AND COLLATERAL MANAGEMENT AGREEMENT

THIS FIRST AMENDMENT TO LOAN, SECURITY AND COLLATERAL MANAGEMENT AGREEMENT (this “Amendment”), dated as of May 14, 2026, is entered into by and among:

(1)

5CLP BDC I ABL SPV-A LLC, a Delaware limited liability company, as the borrower (the “Borrower”);

(2)

each of the lenders party TO THE AGREEMENT;

(3)

Ally Bank, as the administrative agent (“AllyBank” and in such capacity, the “AdministrativeAgent”) and the swingline lender (in such capacity, the “Swingline Lender”);

(4)

5C LENDING PARTNERS ADVISOR LLC, a Delaware limited liability company (the “Collateral Manager”); and

(5)

5C LENDING PARTNERS CORP., a Maryland Corporation (the “Transferor”).

RECITALS

…

EX-10.2·10-Q·CIK 1998387·ACC 0001193125-26-334649·Filed Aug 05, 2026, 14:37 ET

EX-10.1

NVR INC

FIFTH AMENDMENT TO SECOND AMENDED AND RESTATED
MASTER REPURCHASE AGREEMENT

THIS FIFTH AMENDMENT TO SECOND AMENDED AND RESTATED MASTER REPURCHASE AGREEMENT (this “Amendment”), dated as of July 10, 2026 (the “Effective Date”), is made and entered into among NVR MORTGAGE FINANCE, INC., a Virginia corporation (the “Seller”), U.S. BANK NATIONAL ASSOCIATION, as agent (in such capacity, the “Agent”) and a Buyer, and the other Buyers (the “Buyers”).

RECITALS

…

EX-10.1·10-Q·CIK 906163·ACC 0000906163-26-000093·Filed Aug 05, 2026, 14:36 ET

EX-10.2

WESTLAKE CORP

THIRD AMENDMENT TO

AMENDED AND RESTATED SENIOR UNSECURED

REVOLVING CREDIT AGREEMENT

This THIRD AMENDMENT TO AMENDED AND RESTATED SENIOR UNSECURED REVOLVING CREDIT AGREEMENT(this “Amendment”) is made and entered into as of July 8, 2026, by and among WESTLAKE CHEMICAL OPCO LP, a Delaware limited partnership (“Borrower”), as borrower, WESTLAKE POLYMERS LLC, a Delaware limited liability company, as administrative agent (the “Agent”), and the lenders party thereto (the “Lenders”).

W I T N E S S E T H

WHEREAS, Borrower, the Agent and the Lenders entered into that certain Amended and Restated Senior Unsecured Revolving Credit Agreement, dated as of June 1, 2017, as amended by the First Amendment thereto, dated as of September 25, 2018, and the Second Amendment thereto, dated as of July 12, 2022 (as so amended, the “Credit Agreement”), pursuant to which the Lenders have made certain financial accommodations available to Borrower; and

…

EX-10.2·10-Q·CIK 1262823·ACC 0001262823-26-000032·Filed Aug 05, 2026, 14:27 ET